Clinical Trial Update: A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE) [Phase 2]

View source ↗

Summary

This clinical trial update notes a Phase 2 study to evaluate different doses of BI 3000202 in people with systemic lupus erythematosus, which is currently recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• BI 3000202

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Systemic Lupus Erythematosus | Phase 2 | Status: RECRUITING